Aviad Friedman's most recent trade in Oramed Pharmaceuticals, Inc was a trade of 10,000 Stock Option (right to buy done . Disclosure was reported to the exchange on Jan. 3, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc | Aviad Friedman | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 0 | - | - | Stock Option (right to buy | |
| Oramed Pharmaceuticals Inc | Aviad Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy | |
| Oramed Pharmaceuticals Inc | Aviad Friedman | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jan 2022 | 6,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Oramed Pharmaceuticals Inc | Aviad Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 6,000 | 6,000 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Aviad Friedman | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Aug 2021 | 12,191 | 0 (0%) | 0% | 0 | Common Stock | |
| Oramed Pharmaceuticals Inc | Aviad Friedman | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Aug 2021 | 10,000 | 0 (0%) | 0% | 0 | Common Stock |